Variant report

Variant	esv3447912
Chromosome Location	chr9:21260652-21290903
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr9:21268139-21268356	GM12878	blood:	n/a	n/a
2	CHD1	chr9:21268063-21268075	GM12878	blood:	n/a	n/a
3	CTCF	chr9:21265660-21265810	GM12869	blood:	n/a	chr9:21265686-21265695 chr9:21265686-21265699 chr9:21265688-21265698 chr9:21265683-21265701
4	CTCF	chr9:21269642-21269703	GM19239	blood:	n/a	n/a
5	CTCF	chr9:21265634-21265685	Hela-S3	cervix:	n/a	n/a
6	CTCF	chr9:21265603-21265724	GM19238	blood:	n/a	chr9:21265686-21265695 chr9:21265686-21265699 chr9:21265688-21265698 chr9:21265683-21265701
7	CTCF	chr9:21265193-21265228	GM13976	blood:	n/a	n/a
8	CTCF	chr9:21288676-21288707	Kidney_OC	kidney:	n/a	n/a
9	CTCF	chr9:21265560-21265710	GM12872	blood:	n/a	chr9:21265686-21265695 chr9:21265686-21265699 chr9:21265688-21265698 chr9:21265683-21265701
10	CTCF	chr9:21265687-21265769	NHEK	skin:	n/a	chr9:21265688-21265698
11	CTCF	chr9:21289780-21289930	HFF	foreskin:	n/a	n/a
12	CUX1	chr9:21268199-21268312	GM12878	blood:	n/a	n/a
13	EBF1	chr9:21266749-21267054	GM12878	blood:	n/a	n/a
14	EBF1	chr9:21266658-21267283	GM12878	blood:	n/a	n/a
15	EBF1	chr9:21267819-21268499	GM12878	blood:	n/a	n/a
16	EP300	chr9:21267890-21268007	GM12878	blood:	n/a	n/a
17	FAM48A	chr9:21282255-21282345	GM12878	blood:	n/a	n/a
18	GATA2	chr9:21289874-21290218	SH-SY5Y	brain:	n/a	chr9:21290053-21290063 chr9:21290053-21290062 chr9:21290050-21290066
19	GATA3	chr9:21289924-21290166	T-47D	breast:	n/a	chr9:21290053-21290063 chr9:21290053-21290062 chr9:21290054-21290062 chr9:21290050-21290066
20	JUND	chr9:21283697-21283947	HepG2	liver:	n/a	n/a
21	MAFK	chr9:21281471-21281699	HepG2	liver:	n/a	n/a
22	MYC	chr9:21278377-21278402	NB4	blood:	n/a	n/a
23	MYC	chr9:21278331-21278493	H1-hESC	embryonic stem cell:	n/a	n/a
24	POLR2A	chr9:21263766-21264138	MCF10A-Er-Src	breast:	n/a	n/a
25	POLR2A	chr9:21266726-21267081	H1-hESC	embryonic stem cell:	n/a	n/a
26	POLR2A	chr9:21286643-21286984	H1-neurons	neurons:	n/a	n/a
27	POLR2A	chr9:21278557-21278572	A549	lung:	n/a	n/a
28	POLR2A	chr9:21288675-21288833	A549	lung:	n/a	n/a
29	POLR2A	chr9:21277776-21277976	MCF10A-Er-Src	breast:	n/a	n/a
30	POLR2A	chr9:21286629-21287062	H1-neurons	neurons:	n/a	n/a
31	POLR2A	chr9:21288717-21288783	MCF-7	breast:	n/a	n/a
32	POLR2A	chr9:21276687-21276919	MCF10A-Er-Src	breast:	n/a	n/a
33	RCOR1	chr9:21289758-21289774	HepG2	liver:	n/a	n/a
34	RCOR1	chr9:21268001-21268279	GM12878	blood:	n/a	n/a
35	RELA	chr9:21265210-21265801	GM19099	blood:	n/a	n/a
36	REST	chr9:21265417-21265616	Hela-S3	cervix:	n/a	n/a
37	SPI1	chr9:21267830-21268220	GM12891	blood:	n/a	n/a
38	SPI1	chr9:21287337-21287684	GM12891	blood:	n/a	n/a
39	SPI1	chr9:21268229-21268651	GM12891	blood:	n/a	chr9:21268432-21268445 chr9:21268368-21268375 chr9:21268435-21268444 chr9:21268433-21268446
40	SPI1	chr9:21281307-21281501	GM12891	blood:	n/a	chr9:21281419-21281428 chr9:21281416-21281429
41	SPI1	chr9:21267804-21268585	HL-60	blood:	n/a	chr9:21268432-21268445 chr9:21268368-21268375 chr9:21268435-21268444 chr9:21268433-21268446
42	SPI1	chr9:21287320-21287679	HL-60	blood:	n/a	n/a
43	SPI1	chr9:21273571-21273697	GM12878	blood:	n/a	n/a
44	SPI1	chr9:21281310-21281595	HL-60	blood:	n/a	chr9:21281419-21281428 chr9:21281416-21281429
45	SPI1	chr9:21286662-21287050	HL-60	blood:	n/a	n/a
46	SPI1	chr9:21268238-21268586	GM12891	blood:	n/a	chr9:21268432-21268445 chr9:21268368-21268375 chr9:21268435-21268444 chr9:21268433-21268446
47	SPI1	chr9:21268313-21268485	GM12878	blood:	n/a	chr9:21268432-21268445 chr9:21268368-21268375 chr9:21268435-21268444 chr9:21268433-21268446
48	SPI1	chr9:21268263-21268548	GM12878	blood:	n/a	chr9:21268432-21268445 chr9:21268368-21268375 chr9:21268435-21268444 chr9:21268433-21268446
49	SPI1	chr9:21287391-21287661	GM12891	blood:	n/a	n/a
50	SPI1	chr9:21281188-21281653	HL-60	blood:	n/a	chr9:21281419-21281428 chr9:21281416-21281429

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-IFNA5-1	chr9:21278049-21278618	NONHSAT130377
2	lnc-IFNA5-1	chr9:21277687-21278562	NONHSAT130376

Variant related genes	Relation type
IFNA22P	TF binding region

Extended variants
information (count: 916 )
Associated
traits (count: 153 )

Variant overlapped rSNPs/rCNVs (count:916 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs535663011	chr9:21264812-21264813	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs555533098	chr9:21264816-21264817	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs3903111	chr9:21264850-21264851	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
4	rs10964942	chr9:21264883-21264884	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs547337477	chr9:21264927-21264928	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs563361507	chr9:21264950-21264951	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs576784035	chr9:21264965-21264966	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs545736562	chr9:21265017-21265018	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs374096752	chr9:21265042-21265043	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs559692800	chr9:21265057-21265058	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs528384535	chr9:21265062-21265063	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs548448650	chr9:21265139-21265140	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs79427974	chr9:21265140-21265141	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs531064635	chr9:21265152-21265153	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs1330325	chr9:21265197-21265198	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
16	rs570897568	chr9:21265201-21265202	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs369380032	chr9:21265238-21265239	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs539455842	chr9:21265246-21265247	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs1543640	chr9:21265259-21265260	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
20	rs150429637	chr9:21265281-21265282	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs113413426	chr9:21265308-21265309	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs73649577	chr9:21265312-21265313	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs138248959	chr9:21265395-21265396	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs149618123	chr9:21265470-21265471	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs7037707	chr9:21265500-21265501	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
26	rs186586910	chr9:21265542-21265543	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs559386832	chr9:21265564-21265565	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs190614316	chr9:21265580-21265581	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs542127823	chr9:21265588-21265589	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs561932791	chr9:21265614-21265615	Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs530643645	chr9:21265615-21265616	Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs6475527	chr9:21265617-21265618	Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
33	rs10964943	chr9:21265633-21265634	Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs576455246	chr9:21265697-21265698	Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs116133021	chr9:21265716-21265717	Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs373578737	chr9:21265721-21265722	Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs111792943	chr9:21265729-21265730	Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs535505389	chr9:21265769-21265770	Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs140169975	chr9:21265770-21265771	Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs553909745	chr9:21265780-21265781	Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs375626482	chr9:21265783-21265784	Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs112522581	chr9:21265784-21265785	Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs7037805	chr9:21265798-21265799	Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
44	rs370712233	chr9:21265804-21265805	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs183167085	chr9:21265809-21265810	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs374773321	chr9:21265877-21265878	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs561250555	chr9:21265886-21265887	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs559286877	chr9:21265908-21265909	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs368826883	chr9:21265941-21265942	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs373517714	chr9:21266021-21266022	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:153)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic myeloid leukemia	21384125	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Cancer	22183965	CNVD
Glioblastoma multiforme	21569311	CNVD
Myelofibrosis	22110671	CNVD
Ewing''s sarcoma	22429812	CNVD
Neuroblastoma	21899760	CNVD
Glioblastoma multiforme	19435819	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Glioblastoma multiforme	22291905	CNVD
Lung cancer	21911935	CNVD
Primary central nervous system lymphoma	21088137	CNVD
head and neck squamous cell carcinoma	21798897	CNVD
Cancer	21253487	CNVD
Glioblastoma multiforme	22286061	CNVD
Intracranial ependymoma	16609018	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Glioblastoma multiforme	21922591	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Urothelial cell carcinoma	18451213	CNVD
Glioma	17123091	CNVD
Mental retardation	17124404	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Acute lymphoblastic leukemia	18768390	CNVD
Leukemia	19602459	CNVD
Acute monocytic leukemia	16498392	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Leukemia	18688285	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Acute myeloid leukemia	19651601	CNVD
Coronary Disease	20032323	CNVD
Squamous cell cancer	20885788	CNVD
Hirschsprung''s Disease	21712996	CNVD
Cancer	21732550	CNVD
Gastric cancer	22539939	CNVD
Cancer	21183584	CNVD
T-cell lymphomas	19863542	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Metastatic melanoma	18483359	CNVD
Non-small cell lung cancer	20864512	CNVD
Cervical cancer	21062161	CNVD
Acute myeloid leukemia	16864856	CNVD
Glioblastoma	17090523	CNVD
Lung cancer	16773561	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16774939	CNVD
Bladder cancer	19088036	CNVD
Colorectal cancer	16272173	CNVD
Melanoma	16977458	CNVD
Glioblastoma multiforme	17369134	CNVD
Chagasic megaesophagus	20163722	CNVD
Melanoma	19566914	CNVD
Squamous cell cancer	19047905	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Hodgkin''s lymphoma	18179710	CNVD
Glioma	20126413	CNVD
Melanoma	17363583	CNVD
Glioblastoma multiforme	19115005	CNVD
Glioblastoma multiforme	21525872	CNVD
Glioblastoma multiforme	21138945	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Breast cancer	21364760	CNVD
Cancer	20581869	CNVD
Multiple myeloma	17550852	CNVD
Intellectual disability	22102821	CNVD
Oral cancer	22144094	CNVD
Lung cancer	21569311	CNVD
Epilepsy	20502679	CNVD
Barrett''s syndrome	19417022	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Breast cancer	22522925	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD

Chromatin state (count:74 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:21264800-21265400	Enhancers	Cortex derived primary cultured neurospheres	brain
2	chr9:21264800-21268600	Enhancers	Breast Myoepithelial Primary Cells	Breast
3	chr9:21265200-21265800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
4	chr9:21265400-21265600	Enhancers	Primary hematopoietic stem cells short term culture	blood
5	chr9:21265400-21266800	Weak transcription	Cortex derived primary cultured neurospheres	brain
6	chr9:21265600-21265800	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
7	chr9:21265600-21266000	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
8	chr9:21265600-21266000	Enhancers	Fetal Thymus	thymus
9	chr9:21265600-21267200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
10	chr9:21266600-21266800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
11	chr9:21266800-21267000	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
12	chr9:21266800-21267200	Enhancers	GM12878-XiMat	blood
13	chr9:21266800-21267400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
14	chr9:21266800-21267600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
15	chr9:21266800-21268600	Enhancers	Cortex derived primary cultured neurospheres	brain
16	chr9:21267000-21267400	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
17	chr9:21267200-21267600	Enhancers	Primary hematopoietic stem cells short term culture	blood
18	chr9:21267200-21267600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
19	chr9:21267200-21268000	Weak transcription	GM12878-XiMat	blood
20	chr9:21267200-21268600	Enhancers	Primary hematopoietic stem cells	blood
21	chr9:21267200-21268800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
22	chr9:21267400-21268000	Active TSS	Brain Anterior Caudate	brain
23	chr9:21267400-21268400	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
24	chr9:21267600-21267800	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
25	chr9:21267600-21267800	Enhancers	Brain Cingulate Gyrus	brain
26	chr9:21267600-21268200	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
27	chr9:21267600-21268600	Enhancers	Primary monocytes fromperipheralblood	blood
28	chr9:21267600-21268600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
29	chr9:21267800-21268000	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
30	chr9:21267800-21268000	Enhancers	Primary hematopoietic stem cells short term culture	blood
31	chr9:21267800-21268000	Enhancers	Monocytes-CD14+_RO01746	blood
32	chr9:21267800-21268400	Enhancers	Primary B cells from cord blood	blood
33	chr9:21267800-21268600	Enhancers	Primary neutrophils fromperipheralblood	blood
34	chr9:21268000-21268200	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
35	chr9:21268000-21268200	Enhancers	Brain Anterior Caudate	brain
36	chr9:21268000-21268200	Active TSS	GM12878-XiMat	blood
37	chr9:21268000-21268400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
38	chr9:21268000-21268600	Enhancers	Primary B cells from peripheral blood	blood
39	chr9:21268200-21268400	Enhancers	Adipose Nuclei	Adipose
40	chr9:21268200-21268400	Flanking Active TSS	Brain Anterior Caudate	brain
41	chr9:21268200-21268400	Flanking Active TSS	GM12878-XiMat	blood
42	chr9:21268200-21268800	Enhancers	Primary hematopoietic stem cells short term culture	blood
43	chr9:21268400-21268600	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
44	chr9:21268400-21268600	Enhancers	Brain Cingulate Gyrus	brain
45	chr9:21268400-21268600	Enhancers	GM12878-XiMat	blood
46	chr9:21268400-21268800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
47	chr9:21268600-21268800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
48	chr9:21276000-21276600	Enhancers	Primary neutrophils fromperipheralblood	blood
49	chr9:21276600-21281200	Weak transcription	Primary neutrophils fromperipheralblood	blood
50	chr9:21281200-21282000	Enhancers	Primary neutrophils fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links